Product Information
IRBESARTAN 75 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0807 per EA under NDC 62332004190. Its NADAC has been published 497 times since Dec 21, 2016.
Strength
75 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332004190
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA091236On Market Since
7/1/2016
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 75 MG TABLET has been published 497 times since Dec 21, 2016, and over the history we have for it it has declined 58.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0807 per EA |
|---|---|
| All-time high | $0.3279 (Jan 15, 2020) |
| All-time low | $0.0800 (May 20, 2026) |
| 52-week high | $0.1157 |
| 52-week low | $0.0800 |
| Median price | $0.1616 |
| Average price | $0.1660 |
| Largest weekly change | +39.1% (Dec 18, 2019) |
| Weeks tracked | 497 |
| Tracking since | Dec 21, 2016 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IRBESARTAN 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 75 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.0807 per EA (NDC 62332004190), effective Jun 24, 2026.
How has the price of IRBESARTAN 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 75 MG TABLET has declined 58.5%. It has been tracked across 497 weekly CMS publications since Dec 21, 2016.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 75 MG TABLET?
Since Dec 21, 2016, the NADAC for IRBESARTAN 75 MG TABLET has ranged from a low of $0.0800 (May 20, 2026) to a high of $0.3279 (Jan 15, 2020), with a median of $0.1616 per EA.
Are there cheaper alternatives to IRBESARTAN 75 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as IRBESARTAN 75 MG TABLET, but none are currently priced below it.
Who manufactures IRBESARTAN 75 MG TABLET?
IRBESARTAN 75 MG TABLET (NDC 62332004190) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification